Another study that shed more light on this issue, conducted by Ogiya et al., showed that BM MSCs produce IL-6, which binds to its receptor IL-6R on myeloma cells and this causes CD38 downregulation via the JAK-STAT3 pathway (61). Here, IL6 is linked to plasma cell myeloma.